These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 27142176)
21. Intrathecal baclofen therapy for severe spasticity: analysis on a series of 112 consecutive patients and future prospectives. Natale M; Mirone G; Rotondo M; Moraci A Clin Neurol Neurosurg; 2012 May; 114(4):321-5. PubMed ID: 22104692 [TBL] [Abstract][Full Text] [Related]
24. Effect of intrathecal baclofen on sleep and respiratory function in patients with spasticity. Bensmail D; Quera Salva MA; Roche N; Benyahia S; Bohic M; Denys P; Bussel B; Lofaso F Neurology; 2006 Oct; 67(8):1432-6. PubMed ID: 17060570 [TBL] [Abstract][Full Text] [Related]
25. Intrathecal baclofen for multiple sclerosis related spasticity: A twenty year experience. Sammaraiee Y; Yardley M; Keenan L; Buchanan K; Stevenson V; Farrell R Mult Scler Relat Disord; 2019 Jan; 27():95-100. PubMed ID: 30366276 [TBL] [Abstract][Full Text] [Related]
26. [Results of intrathecal baclofen therapy on spasticity in patients with brain injury]. Dénes Z; Klauber A; Both B; Lóránd E Ideggyogy Sz; 2012 Jul; 65(7-8):243-8; discussion 248. PubMed ID: 23074844 [TBL] [Abstract][Full Text] [Related]
27. Efficacy of intrathecal baclofen delivery in the management of severe spasticity in upper motor neuron syndrome. Rietman JS; Geertzen JH Acta Neurochir Suppl; 2007; 97(Pt 1):205-11. PubMed ID: 17691378 [TBL] [Abstract][Full Text] [Related]
28. Effect of intrathecal baclofen bolus injection on temporospatial gait characteristics in patients with acquired brain injury. Horn TS; Yablon SA; Stokic DS Arch Phys Med Rehabil; 2005 Jun; 86(6):1127-33. PubMed ID: 15954050 [TBL] [Abstract][Full Text] [Related]
29. European expert consensus on improving patient selection for the management of disabling spasticity with intrathecal baclofen and/or botulinum toxin type A. Biering-Soerensen B; Stevenson V; Bensmail D; Grabljevec K; Martínez Moreno M; Pucks-Faes E; Wissel J; Zampolini M J Rehabil Med; 2022 Jan; 54():jrm00241. PubMed ID: 34608495 [TBL] [Abstract][Full Text] [Related]
30. Intraventricular baclofen as an alternative to intrathecal baclofen for intractable spasticity or dystonia: outcomes and technical considerations. Turner M; Nguyen HS; Cohen-Gadol AA J Neurosurg Pediatr; 2012 Oct; 10(4):315-9. PubMed ID: 22861196 [TBL] [Abstract][Full Text] [Related]
32. Intrathecal baclofen therapy in paediatrics: a study protocol for an Australian multicentre, 10-year prospective audit. Stewart K; Hutana G; Kentish M BMJ Open; 2017 Jun; 7(6):e015863. PubMed ID: 28637739 [TBL] [Abstract][Full Text] [Related]
33. Weight changes in children receiving intrathecal baclofen for the treatment of spasticity. Pritula SL; Fox MA; Ayyangar R J Pediatr Rehabil Med; 2012; 5(3):197-201. PubMed ID: 23023252 [TBL] [Abstract][Full Text] [Related]
34. [Quality of life in cerebral palsy children treated with intrathecal baclofen pump implantation in parents' opinion]. Borowski A; Pruszczyński B; Miller F; Synder M Chir Narzadow Ruchu Ortop Pol; 2010; 75(5):318-22. PubMed ID: 21853903 [TBL] [Abstract][Full Text] [Related]
35. The underutilization of intrathecal baclofen in poststroke spasticity. Dvorak EM; Ketchum NC; McGuire JR Top Stroke Rehabil; 2011; 18(3):195-202. PubMed ID: 21642057 [TBL] [Abstract][Full Text] [Related]